FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 617 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant Annual Multicancer Early Detection Test Not Associated with a Lower Incidence Rate of Stage III or IV Cancer After Three Screening Rounds and 12... MOST POPULAR What to Know About Exercising During Prostate Cancer: An Expert Q&A August 8, 2023 Final DFS Analysis Demonstrates that Adjuvant Osimertinib Improves DFS in Patients... February 13, 2023 National Study Examines Genetic Testing to Inform Follow-up Care for Cancer... May 7, 2026 Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for... May 19, 2026 Load more HOT NEWS 12-Yr-Old Chokes Up When Nurses Surprise Him With Special Song For... Animal Shelters Are Honoring Healthcare Workers By Naming Shelter Dogs After... Smoking among young adults increased by 25% during first lockdown The Right to be Forgotten: ESMO Calls on EU Countries to...
